AEGON LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.781 EUR | -1.78% |
|
-1.19% | +10.00% |
| Jul. 08 | Aegon: start of share buyback program | CF |
| Jul. 08 | Aegon Kicks Off EUR200 Million Share Buyback | MT |
Strengths
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company's share price in relation to its net book value makes it look relatively cheap.
- This company will be of major interest to investors in search of a high dividend stock.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Life & Health Insurance
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +10.00% | 10.98B | - | ||
| +8.55% | 76.16B | B- | ||
| +7.30% | 50.6B | B | ||
| +4.96% | 49.42B | B+ | ||
| +25.85% | 47.7B | B+ | ||
| +12.85% | 41.95B | B+ | ||
| +25.26% | 39.75B | B | ||
| +18.76% | 33.22B | B | ||
| -2.43% | 28.38B | B | ||
| +36.17% | 27.7B | A |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- AGN Stock
- AGN Stock
- Ratings Aegon Ltd.
